AXT, Inc. 2022 Q3 Form 10-Q Summary
Business context and reporting period
AXT develops and manufactures compound and single-element semiconductor substrates, including indium phosphide, gallium arsenide and germanium wafers, and sells related raw materials. Manufacturing is conducted through subsidiaries and joint ventures in China. The filing covers the three and nine months ended September 30, 2022, compared with the corresponding 2021 periods. The financial statements are unaudited.
Key financial metrics
| Metric | Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 |
|---|---|---|---|---|
| Revenue | $35.2 million | $34.6 million | $114.3 million | $99.7 million |
| Gross profit | $14.8 million | $11.5 million | $43.5 million | $35.3 million |
| Gross margin | 42.0% | 33.3% | 38.1% | 35.4% |
| Income from operations | $4.6 million | $2.4 million | $13.6 million | $9.9 million |
| Net income attributable to AXT | $5.8 million | $3.8 million | $14.5 million | $11.6 million |
| Diluted EPS | $0.13 | $0.09 | $0.34 | $0.27 |
| Net cash used in operating activities | Not separately presented | Not separately presented | $(9.3) million | $(10.7) million |
| Capital expenditures | Not separately presented | Not separately presented | $28.8 million | $19.1 million |
Q3 operating margin was approximately 13.0%, compared with approximately 6.9% in the prior-year quarter. The improvement primarily reflected higher yields, recycling of indium phosphide processing remnants, stronger margins at two raw-material companies and a more favorable product mix.
- Substrate revenue increased 2.7% in Q3 and 21.3% for the first nine months, driven primarily by InP demand associated with 5G, data-center connectivity and related applications.
- Raw-material revenue decreased 1.2% in Q3 and 4.8% for the first nine months.
- Research and development expense increased 38.4% in Q3 and 35.4% for the first nine months, reflecting personnel and development spending for 8-inch GaAs and 6-inch InP products.
- Equity income from unconsolidated joint ventures increased to $2.0 million in Q3 and $5.3 million for the first nine months, benefiting from higher volumes and prices at two raw-gallium companies.
- Income taxes were $0.5 million in Q3 and $2.2 million for the first nine months, compared with a $0.1 million benefit and $1.5 million expense, respectively, in the comparable 2021 periods.
Balance sheet, debt and liquidity
- Cash, restricted cash and cash equivalents totaled $36.8 million at September 30, 2022, including $3.9 million of restricted cash. Investments totaled $11.4 million, for total cash and investments of $48.2 million.
- Cash and investments declined from $51.8 million at December 31, 2021, while total assets increased to $361.8 million from $332.4 million.
- Inventory increased to $88.5 million from $65.9 million; excess and obsolete inventory reserves were $23.0 million versus $19.6 million at year-end.
- Bank loans increased to $43.0 million from $12.2 million at December 31, 2021. The loans generally mature within 12 months and carry stated interest rates of approximately 2.7% to 4.8%.
- Operating cash flow remained negative because of a $32.7 million increase in inventories and a $5.4 million increase in accounts receivable.
- Financing activities provided $35.3 million, primarily from $42.4 million of bank-loan proceeds, partially offset by $9.8 million of repayments.
- Management states that available cash and investments are adequate for operating needs and capital expenditures over the next 12 months.
Material changes versus the prior comparable period
- Revenue increased $0.6 million, or 1.8%, in Q3 and $14.7 million, or 14.7%, for the first nine months.
- Gross margin expanded 870 basis points in Q3 and 270 basis points for the first nine months.
- Net income attributable to AXT increased 51.6% in Q3 and 24.6% for the first nine months.
- Geographic mix shifted materially in Q3: Taiwan revenue increased 104.3% and North American revenue increased 88.6%, while China revenue declined 27.4%.
- Customer concentration increased: Landmark represented 18% of Q3 revenue and 14% of nine-month revenue; the top five customers represented 40% and 33%, respectively.
- Accumulated other comprehensive income changed from a $6.3 million gain at year-end 2021 to a $5.5 million loss, primarily due to foreign-currency translation losses.
- Property, plant and equipment increased to $152.7 million from $142.4 million, reflecting continued investment in new Chinese facilities and equipment.
Guidance, outlook, risks and unusual items
- No specific revenue, earnings or margin guidance is provided in the filing text. Management expects Tongmei’s STAR Market IPO process to be completed in the fourth quarter of 2022, subject to CSRC and other approvals.
- Tongmei’s private-equity investors have redemption rights of approximately $49 million if the IPO fails required reviews or is canceled. A redemption could require AXT to obtain additional capital and materially affect liquidity.
- The Shanghai Stock Exchange approved Tongmei’s IPO application on July 12, 2022, and the CSRC accepted it for review on August 1, 2022; final approval was not yet obtained as of the filing.
- Key operating risks include COVID-19-related shutdowns, Chinese regulatory or environmental intervention, tariffs and trade restrictions, foreign-exchange volatility, customer concentration, product qualification and yield issues, semiconductor cyclicality, raw-material supply disruptions and competition.
- AXT paid approximately $2.6 million in U.S. tariffs during the first nine months of 2022. Approximately 10% of revenue was described as deriving from importing wafers into the United States.
- The company maintains a $90 million targeted investment commitment for its Dingxing project, with similar smaller targets for Kazuo facilities. The filing describes these as good-faith government cooperation arrangements without a specific deadline or stated penalty for breach.
- Other income included a $0.2 million Chinese government relocation grant for the first nine months and foreign-exchange gains of $0.5 million in Q3 and $0.5 million for the first nine months.
- Note 20, “Subsequent Event,” is marked “TBD” in the supplied filing text; the source does not provide a clear subsequent-event disclosure.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether Tongmei received final CSRC and other approvals and completed the STAR Market IPO, or whether redemption rights were triggered.
- The maturity, collateral and refinancing status of the $43.0 million of bank loans.
- Whether elevated inventory, inventory reserves and negative operating cash flow have normalized.
- The sustainability of the 42.0% Q3 gross margin and the contribution from equity-method raw-material companies.
- Customer concentration, particularly Landmark’s contribution and any changes in orders or qualifications.
- Exposure to China-related regulatory, environmental, COVID-19, currency and U.S.-China trade risks, including tariff costs.
- The missing or incomplete subsequent-event disclosure identified as “TBD” in the provided text.